Filing Details
- Accession Number:
- 0001415889-25-008557
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-18 21:30:07
- Reporting Period:
- 2025-03-15
- Filing Date:
- 2025-03-18
- Accepted Time:
- 2025-03-18 21:30:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1759425 | Mirum Pharmaceuticals Inc. | MIRM | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1650131 | Peter Radovich | C/O Mirum Pharmaceuticals, Inc. 989 E Hillsdale Blvd., Suite 300 Foster City CA 94404 | President And Coo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-03-15 | 14,440 | $0.00 | 26,551 | No | 4 | M | Direct | |
Common Stock | Disposition | 2025-03-17 | 7,879 | $44.21 | 18,672 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Performance Restricted Stock Units | Disposition | 2025-03-15 | 14,440 | $0.00 | 14,440 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,220 | No | 4 | M | Direct |
Footnotes
- Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units.
- The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026.